Rankings
▼
Calendar
OMER Q1 2017 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$821M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
+65.2% YoY
Gross Profit
$12M
97.8% margin
Operating Income
-$13M
-103.8% margin
Net Income
-$15M
-123.1% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
-5.0%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$58M
Total Liabilities
$107M
Stockholders' Equity
-$48M
Cash & Equivalents
$1M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$7M
+65.2%
Gross Profit
$12M
$7M
+69.0%
Operating Income
-$13M
-$19M
+34.6%
Net Income
-$15M
-$21M
+26.5%
← FY 2017
All Quarters
Q2 2017 →